AFL can be treated through catheter ablation, especially if medications or electrical cardioversion (shocking the heart back to a normal rhythm) are unsuccessful. In the minimally invasive procedure, ...

This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...

First-line treatment with catheter ablation is superior to drug therapy for reducing atrial fibrillation, according to five year results from the MANTRA-PAF trial presented for the first time at ESC ...

Johnson & Johnson (NYSE:JNJ) announced today that it received FDA approval for its dual-energy ThermoCool SmartTouch SF ...

Researchers conducted a retrospective cohort study comparing the efficacy of first-time catheter ablation between young and older adults with AF who underwent the procedure between 2016 and 2023. The ...

Please provide your email address to receive an email when new articles are posted on . A new cost-utility analysis has shown that catheter ablation as a second-line intervention is likely ...

The investigational Farawave Ultra pulsed-field ablation (PFA) catheter could expand Boston Scientific's lead over the ...

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased ...

Biosense Webster, Inc., part of Johnson & Johnson MedTech, today announced the European launch of the HELIOSTAR ™ Balloon Ablation Catheter – the first radiofrequency balloon ablation catheter – The ...

Johnson & Johnson recently received U.S. FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform, an ablation ...

Use of catheter ablation is not only beneficial for treating atrial flutter but also can significantly reduce hospital visits – both inpatient and emergency – and lower the risk for atrial ...